nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—MTHFR—osteoporosis	0.367	1	CbGaD
Fluorouracil—ABCC3—Conjugated Estrogens—osteoporosis	0.0664	0.175	CbGbCtD
Fluorouracil—ABCC4—Conjugated Estrogens—osteoporosis	0.0507	0.134	CbGbCtD
Fluorouracil—ALB—Estropipate—osteoporosis	0.0397	0.105	CbGbCtD
Fluorouracil—ABCG2—Conjugated Estrogens—osteoporosis	0.0273	0.0718	CbGbCtD
Fluorouracil—ABCG2—Estradiol—osteoporosis	0.0239	0.0631	CbGbCtD
Fluorouracil—CYP1A2—Estropipate—osteoporosis	0.0238	0.0626	CbGbCtD
Fluorouracil—CYP2C9—Estropipate—osteoporosis	0.0214	0.0564	CbGbCtD
Fluorouracil—CYP2C8—Raloxifene—osteoporosis	0.0205	0.054	CbGbCtD
Fluorouracil—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0198	0.0521	CbGbCtD
Fluorouracil—ALB—Estradiol—osteoporosis	0.0165	0.0435	CbGbCtD
Fluorouracil—CYP2C8—Cholecalciferol—osteoporosis	0.0158	0.0417	CbGbCtD
Fluorouracil—CYP2C8—Estradiol—osteoporosis	0.0128	0.0336	CbGbCtD
Fluorouracil—CYP1A2—Conjugated Estrogens—osteoporosis	0.0112	0.0296	CbGbCtD
Fluorouracil—CYP2C9—Cholecalciferol—osteoporosis	0.011	0.0291	CbGbCtD
Fluorouracil—CYP1A2—Estradiol—osteoporosis	0.00987	0.026	CbGbCtD
Fluorouracil—CYP2C9—Estradiol—osteoporosis	0.0089	0.0234	CbGbCtD
Fluorouracil—UMPS—uterus—osteoporosis	0.000834	0.121	CbGeAlD
Fluorouracil—UPP1—uterus—osteoporosis	0.000765	0.111	CbGeAlD
Fluorouracil—UMPS—bone marrow—osteoporosis	0.000708	0.102	CbGeAlD
Fluorouracil—UPP1—bone marrow—osteoporosis	0.000649	0.0939	CbGeAlD
Fluorouracil—DPYD—uterus—osteoporosis	0.000621	0.0898	CbGeAlD
Fluorouracil—TYMS—Levorphanol—Estradiol—osteoporosis	0.000621	0.469	CbGdCrCtD
Fluorouracil—DPYD—bone marrow—osteoporosis	0.000527	0.0762	CbGeAlD
Fluorouracil—PPAT—bone marrow—osteoporosis	0.000456	0.066	CbGeAlD
Fluorouracil—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.00041	0.309	CbGdCrCtD
Fluorouracil—TYMP—uterus—osteoporosis	0.00036	0.052	CbGeAlD
Fluorouracil—TYMP—bone marrow—osteoporosis	0.000305	0.0442	CbGeAlD
Fluorouracil—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000294	0.222	CbGdCrCtD
Fluorouracil—SLC29A1—uterus—osteoporosis	0.000277	0.04	CbGeAlD
Fluorouracil—TYMS—bone marrow—osteoporosis	0.000262	0.0379	CbGeAlD
Fluorouracil—ABCC5—bone marrow—osteoporosis	0.000256	0.037	CbGeAlD
Fluorouracil—SLC29A1—bone marrow—osteoporosis	0.000235	0.034	CbGeAlD
Fluorouracil—ABCC4—uterus—osteoporosis	0.000209	0.0302	CbGeAlD
Fluorouracil—Pain—Raloxifene—osteoporosis	0.000178	0.00127	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000178	0.00127	CcSEcCtD
Fluorouracil—Chest pain—Risedronate—osteoporosis	0.000178	0.00127	CcSEcCtD
Fluorouracil—Myalgia—Risedronate—osteoporosis	0.000178	0.00127	CcSEcCtD
Fluorouracil—Leukopenia—Pamidronate—osteoporosis	0.000177	0.00126	CcSEcCtD
Fluorouracil—ABCC4—bone marrow—osteoporosis	0.000177	0.0257	CbGeAlD
Fluorouracil—Alopecia—Conjugated Estrogens—osteoporosis	0.000177	0.00126	CcSEcCtD
Fluorouracil—Pain—Ibandronate—osteoporosis	0.000177	0.00126	CcSEcCtD
Fluorouracil—Pruritus—Etidronic acid—osteoporosis	0.000176	0.00126	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Estradiol—osteoporosis	0.000176	0.00125	CcSEcCtD
Fluorouracil—Decreased appetite—Calcitriol—osteoporosis	0.000176	0.00125	CcSEcCtD
Fluorouracil—Myocardial infarction—Estradiol—osteoporosis	0.000175	0.00125	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Estradiol—osteoporosis	0.000175	0.00125	CcSEcCtD
Fluorouracil—Feeling abnormal—Alendronate—osteoporosis	0.000175	0.00125	CcSEcCtD
Fluorouracil—Oedema—Ethinyl Estradiol—osteoporosis	0.000175	0.00124	CcSEcCtD
Fluorouracil—Erythema—Conjugated Estrogens—osteoporosis	0.000174	0.00124	CcSEcCtD
Fluorouracil—Urinary tract infection—Estradiol—osteoporosis	0.000174	0.00124	CcSEcCtD
Fluorouracil—Conjunctivitis—Estradiol—osteoporosis	0.000174	0.00124	CcSEcCtD
Fluorouracil—Infection—Ethinyl Estradiol—osteoporosis	0.000173	0.00124	CcSEcCtD
Fluorouracil—Pain—Calcitriol—osteoporosis	0.000173	0.00123	CcSEcCtD
Fluorouracil—Convulsion—Pamidronate—osteoporosis	0.000172	0.00122	CcSEcCtD
Fluorouracil—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000171	0.00122	CcSEcCtD
Fluorouracil—Urticaria—Estropipate—osteoporosis	0.000171	0.00122	CcSEcCtD
Fluorouracil—Vision blurred—Zoledronate—osteoporosis	0.000171	0.00122	CcSEcCtD
Fluorouracil—Diarrhoea—Etidronic acid—osteoporosis	0.00017	0.00121	CcSEcCtD
Fluorouracil—Body temperature increased—Estropipate—osteoporosis	0.00017	0.00121	CcSEcCtD
Fluorouracil—Feeling abnormal—Ibandronate—osteoporosis	0.00017	0.00121	CcSEcCtD
Fluorouracil—Infection—Risedronate—osteoporosis	0.000169	0.0012	CcSEcCtD
Fluorouracil—Myalgia—Pamidronate—osteoporosis	0.000169	0.0012	CcSEcCtD
Fluorouracil—Urticaria—Alendronate—osteoporosis	0.000168	0.0012	CcSEcCtD
Fluorouracil—Epistaxis—Estradiol—osteoporosis	0.000168	0.0012	CcSEcCtD
Fluorouracil—Body temperature increased—Alendronate—osteoporosis	0.000168	0.00119	CcSEcCtD
Fluorouracil—Sinusitis—Estradiol—osteoporosis	0.000168	0.00119	CcSEcCtD
Fluorouracil—Anaemia—Zoledronate—osteoporosis	0.000167	0.00119	CcSEcCtD
Fluorouracil—Nervous system disorder—Risedronate—osteoporosis	0.000167	0.00119	CcSEcCtD
Fluorouracil—Discomfort—Pamidronate—osteoporosis	0.000167	0.00119	CcSEcCtD
Fluorouracil—Body temperature increased—Raloxifene—osteoporosis	0.000165	0.00118	CcSEcCtD
Fluorouracil—Vision blurred—Conjugated Estrogens—osteoporosis	0.000164	0.00117	CcSEcCtD
Fluorouracil—Urticaria—Ibandronate—osteoporosis	0.000164	0.00117	CcSEcCtD
Fluorouracil—Body temperature increased—Ibandronate—osteoporosis	0.000163	0.00116	CcSEcCtD
Fluorouracil—Confusional state—Pamidronate—osteoporosis	0.000163	0.00116	CcSEcCtD
Fluorouracil—Leukopenia—Zoledronate—osteoporosis	0.000162	0.00116	CcSEcCtD
Fluorouracil—Anaphylactic shock—Pamidronate—osteoporosis	0.000162	0.00115	CcSEcCtD
Fluorouracil—Oedema—Pamidronate—osteoporosis	0.000162	0.00115	CcSEcCtD
Fluorouracil—Haemoglobin—Estradiol—osteoporosis	0.000161	0.00115	CcSEcCtD
Fluorouracil—Infection—Pamidronate—osteoporosis	0.000161	0.00115	CcSEcCtD
Fluorouracil—Rhinitis—Estradiol—osteoporosis	0.000161	0.00115	CcSEcCtD
Fluorouracil—Urticaria—Calcitriol—osteoporosis	0.000161	0.00114	CcSEcCtD
Fluorouracil—Haemorrhage—Estradiol—osteoporosis	0.00016	0.00114	CcSEcCtD
Fluorouracil—Body temperature increased—Calcitriol—osteoporosis	0.00016	0.00114	CcSEcCtD
Fluorouracil—Hypoaesthesia—Estradiol—osteoporosis	0.000159	0.00114	CcSEcCtD
Fluorouracil—Pharyngitis—Estradiol—osteoporosis	0.000159	0.00113	CcSEcCtD
Fluorouracil—Hypersensitivity—Estropipate—osteoporosis	0.000159	0.00113	CcSEcCtD
Fluorouracil—Nervous system disorder—Pamidronate—osteoporosis	0.000159	0.00113	CcSEcCtD
Fluorouracil—Thrombocytopenia—Pamidronate—osteoporosis	0.000158	0.00113	CcSEcCtD
Fluorouracil—Vomiting—Etidronic acid—osteoporosis	0.000158	0.00113	CcSEcCtD
Fluorouracil—Tachycardia—Pamidronate—osteoporosis	0.000158	0.00113	CcSEcCtD
Fluorouracil—Rash—Etidronic acid—osteoporosis	0.000157	0.00112	CcSEcCtD
Fluorouracil—Convulsion—Zoledronate—osteoporosis	0.000157	0.00112	CcSEcCtD
Fluorouracil—Dermatitis—Etidronic acid—osteoporosis	0.000157	0.00112	CcSEcCtD
Fluorouracil—Hypersensitivity—Alendronate—osteoporosis	0.000156	0.00111	CcSEcCtD
Fluorouracil—Headache—Etidronic acid—osteoporosis	0.000156	0.00111	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000155	0.0011	CcSEcCtD
Fluorouracil—Anorexia—Pamidronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Fluorouracil—Chest pain—Zoledronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Fluorouracil—Myalgia—Zoledronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Fluorouracil—Insomnia—Risedronate—osteoporosis	0.000154	0.0011	CcSEcCtD
Fluorouracil—Paraesthesia—Risedronate—osteoporosis	0.000153	0.00109	CcSEcCtD
Fluorouracil—Pruritus—Estropipate—osteoporosis	0.000152	0.00109	CcSEcCtD
Fluorouracil—Discomfort—Zoledronate—osteoporosis	0.000152	0.00109	CcSEcCtD
Fluorouracil—Hypersensitivity—Ibandronate—osteoporosis	0.000152	0.00108	CcSEcCtD
Fluorouracil—Dyspnoea—Risedronate—osteoporosis	0.000152	0.00108	CcSEcCtD
Fluorouracil—Hypotension—Pamidronate—osteoporosis	0.000151	0.00108	CcSEcCtD
Fluorouracil—Convulsion—Conjugated Estrogens—osteoporosis	0.000151	0.00108	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000151	0.00107	CcSEcCtD
Fluorouracil—Pruritus—Alendronate—osteoporosis	0.00015	0.00107	CcSEcCtD
Fluorouracil—Dyspepsia—Risedronate—osteoporosis	0.00015	0.00107	CcSEcCtD
Fluorouracil—Confusional state—Zoledronate—osteoporosis	0.000149	0.00106	CcSEcCtD
Fluorouracil—Hypersensitivity—Calcitriol—osteoporosis	0.000149	0.00106	CcSEcCtD
Fluorouracil—Myalgia—Conjugated Estrogens—osteoporosis	0.000148	0.00106	CcSEcCtD
Fluorouracil—Chest pain—Conjugated Estrogens—osteoporosis	0.000148	0.00106	CcSEcCtD
Fluorouracil—Nausea—Etidronic acid—osteoporosis	0.000148	0.00105	CcSEcCtD
Fluorouracil—Oedema—Zoledronate—osteoporosis	0.000148	0.00105	CcSEcCtD
Fluorouracil—Anaphylactic shock—Zoledronate—osteoporosis	0.000148	0.00105	CcSEcCtD
Fluorouracil—ABCG2—uterus—osteoporosis	0.000148	0.0213	CbGeAlD
Fluorouracil—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000147	0.00105	CcSEcCtD
Fluorouracil—Diarrhoea—Estropipate—osteoporosis	0.000147	0.00105	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Risedronate—osteoporosis	0.000147	0.00105	CcSEcCtD
Fluorouracil—Infection—Zoledronate—osteoporosis	0.000147	0.00105	CcSEcCtD
Fluorouracil—Insomnia—Pamidronate—osteoporosis	0.000146	0.00104	CcSEcCtD
Fluorouracil—Pruritus—Ibandronate—osteoporosis	0.000146	0.00104	CcSEcCtD
Fluorouracil—Pain—Risedronate—osteoporosis	0.000146	0.00104	CcSEcCtD
Fluorouracil—Paraesthesia—Pamidronate—osteoporosis	0.000145	0.00104	CcSEcCtD
Fluorouracil—Diarrhoea—Alendronate—osteoporosis	0.000145	0.00103	CcSEcCtD
Fluorouracil—Nervous system disorder—Zoledronate—osteoporosis	0.000145	0.00103	CcSEcCtD
Fluorouracil—Thrombocytopenia—Zoledronate—osteoporosis	0.000145	0.00103	CcSEcCtD
Fluorouracil—Dyspnoea—Pamidronate—osteoporosis	0.000144	0.00103	CcSEcCtD
Fluorouracil—Tachycardia—Zoledronate—osteoporosis	0.000144	0.00103	CcSEcCtD
Fluorouracil—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000144	0.00103	CcSEcCtD
Fluorouracil—Somnolence—Pamidronate—osteoporosis	0.000144	0.00102	CcSEcCtD
Fluorouracil—Pruritus—Calcitriol—osteoporosis	0.000143	0.00102	CcSEcCtD
Fluorouracil—Diarrhoea—Raloxifene—osteoporosis	0.000143	0.00102	CcSEcCtD
Fluorouracil—Dyspepsia—Pamidronate—osteoporosis	0.000142	0.00101	CcSEcCtD
Fluorouracil—Dizziness—Estropipate—osteoporosis	0.000142	0.00101	CcSEcCtD
Fluorouracil—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000142	0.00101	CcSEcCtD
Fluorouracil—Oedema—Conjugated Estrogens—osteoporosis	0.000142	0.00101	CcSEcCtD
Fluorouracil—Alopecia—Estradiol—osteoporosis	0.000142	0.00101	CcSEcCtD
Fluorouracil—Infection—Conjugated Estrogens—osteoporosis	0.000141	0.00101	CcSEcCtD
Fluorouracil—Diarrhoea—Ibandronate—osteoporosis	0.000141	0.00101	CcSEcCtD
Fluorouracil—Anorexia—Zoledronate—osteoporosis	0.000141	0.001	CcSEcCtD
Fluorouracil—Decreased appetite—Pamidronate—osteoporosis	0.000141	0.001	CcSEcCtD
Fluorouracil—Dizziness—Alendronate—osteoporosis	0.00014	0.001	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00014	0.000995	CcSEcCtD
Fluorouracil—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00014	0.000994	CcSEcCtD
Fluorouracil—Erythema—Estradiol—osteoporosis	0.00014	0.000994	CcSEcCtD
Fluorouracil—Tachycardia—Conjugated Estrogens—osteoporosis	0.000139	0.00099	CcSEcCtD
Fluorouracil—Urticaria—Ethinyl Estradiol—osteoporosis	0.000139	0.000988	CcSEcCtD
Fluorouracil—Pain—Pamidronate—osteoporosis	0.000138	0.000986	CcSEcCtD
Fluorouracil—Diarrhoea—Calcitriol—osteoporosis	0.000138	0.000986	CcSEcCtD
Fluorouracil—Hypotension—Zoledronate—osteoporosis	0.000138	0.000984	CcSEcCtD
Fluorouracil—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000138	0.000983	CcSEcCtD
Fluorouracil—Dizziness—Raloxifene—osteoporosis	0.000138	0.000983	CcSEcCtD
Fluorouracil—Vomiting—Estropipate—osteoporosis	0.000137	0.000976	CcSEcCtD
Fluorouracil—Dizziness—Ibandronate—osteoporosis	0.000137	0.000973	CcSEcCtD
Fluorouracil—Rash—Estropipate—osteoporosis	0.000136	0.000968	CcSEcCtD
Fluorouracil—Dermatitis—Estropipate—osteoporosis	0.000136	0.000967	CcSEcCtD
Fluorouracil—Anorexia—Conjugated Estrogens—osteoporosis	0.000136	0.000967	CcSEcCtD
Fluorouracil—Urticaria—Risedronate—osteoporosis	0.000135	0.000963	CcSEcCtD
Fluorouracil—Headache—Estropipate—osteoporosis	0.000135	0.000961	CcSEcCtD
Fluorouracil—Vomiting—Alendronate—osteoporosis	0.000135	0.000961	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000135	0.000959	CcSEcCtD
Fluorouracil—Body temperature increased—Risedronate—osteoporosis	0.000135	0.000959	CcSEcCtD
Fluorouracil—Rash—Alendronate—osteoporosis	0.000134	0.000953	CcSEcCtD
Fluorouracil—Insomnia—Zoledronate—osteoporosis	0.000134	0.000952	CcSEcCtD
Fluorouracil—Dermatitis—Alendronate—osteoporosis	0.000134	0.000952	CcSEcCtD
Fluorouracil—Feeling abnormal—Pamidronate—osteoporosis	0.000133	0.00095	CcSEcCtD
Fluorouracil—Hypotension—Conjugated Estrogens—osteoporosis	0.000133	0.000948	CcSEcCtD
Fluorouracil—Headache—Alendronate—osteoporosis	0.000133	0.000947	CcSEcCtD
Fluorouracil—Paraesthesia—Zoledronate—osteoporosis	0.000133	0.000946	CcSEcCtD
Fluorouracil—Vomiting—Raloxifene—osteoporosis	0.000133	0.000945	CcSEcCtD
Fluorouracil—Dyspnoea—Zoledronate—osteoporosis	0.000132	0.000939	CcSEcCtD
Fluorouracil—Rash—Raloxifene—osteoporosis	0.000132	0.000937	CcSEcCtD
Fluorouracil—Dermatitis—Raloxifene—osteoporosis	0.000131	0.000936	CcSEcCtD
Fluorouracil—Somnolence—Zoledronate—osteoporosis	0.000131	0.000936	CcSEcCtD
Fluorouracil—Vomiting—Ibandronate—osteoporosis	0.000131	0.000936	CcSEcCtD
Fluorouracil—Headache—Raloxifene—osteoporosis	0.000131	0.000931	CcSEcCtD
Fluorouracil—Rash—Ibandronate—osteoporosis	0.00013	0.000928	CcSEcCtD
Fluorouracil—Dermatitis—Ibandronate—osteoporosis	0.00013	0.000927	CcSEcCtD
Fluorouracil—Dyspepsia—Zoledronate—osteoporosis	0.00013	0.000927	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00013	0.000924	CcSEcCtD
Fluorouracil—Headache—Ibandronate—osteoporosis	0.000129	0.000922	CcSEcCtD
Fluorouracil—Insomnia—Conjugated Estrogens—osteoporosis	0.000129	0.000917	CcSEcCtD
Fluorouracil—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000129	0.000916	CcSEcCtD
Fluorouracil—Vomiting—Calcitriol—osteoporosis	0.000129	0.000916	CcSEcCtD
Fluorouracil—Decreased appetite—Zoledronate—osteoporosis	0.000128	0.000915	CcSEcCtD
Fluorouracil—Nausea—Estropipate—osteoporosis	0.000128	0.000912	CcSEcCtD
Fluorouracil—Body temperature increased—Pamidronate—osteoporosis	0.000128	0.000911	CcSEcCtD
Fluorouracil—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000128	0.000911	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000128	0.000909	CcSEcCtD
Fluorouracil—Rash—Calcitriol—osteoporosis	0.000127	0.000908	CcSEcCtD
Fluorouracil—Dermatitis—Calcitriol—osteoporosis	0.000127	0.000907	CcSEcCtD
Fluorouracil—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000127	0.000904	CcSEcCtD
Fluorouracil—Headache—Calcitriol—osteoporosis	0.000127	0.000902	CcSEcCtD
Fluorouracil—Somnolence—Conjugated Estrogens—osteoporosis	0.000126	0.000901	CcSEcCtD
Fluorouracil—Pain—Zoledronate—osteoporosis	0.000126	0.000901	CcSEcCtD
Fluorouracil—Nausea—Alendronate—osteoporosis	0.000126	0.000898	CcSEcCtD
Fluorouracil—Hypersensitivity—Risedronate—osteoporosis	0.000125	0.000894	CcSEcCtD
Fluorouracil—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000125	0.000893	CcSEcCtD
Fluorouracil—ABCG2—bone marrow—osteoporosis	0.000125	0.0181	CbGeAlD
Fluorouracil—Nausea—Raloxifene—osteoporosis	0.000124	0.000883	CcSEcCtD
Fluorouracil—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000124	0.000881	CcSEcCtD
Fluorouracil—Pruritus—Ethinyl Estradiol—osteoporosis	0.000123	0.00088	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000123	0.000875	CcSEcCtD
Fluorouracil—Nausea—Ibandronate—osteoporosis	0.000123	0.000874	CcSEcCtD
Fluorouracil—Feeling abnormal—Zoledronate—osteoporosis	0.000122	0.000868	CcSEcCtD
Fluorouracil—Pain—Conjugated Estrogens—osteoporosis	0.000122	0.000867	CcSEcCtD
Fluorouracil—Pruritus—Risedronate—osteoporosis	0.00012	0.000858	CcSEcCtD
Fluorouracil—Nausea—Calcitriol—osteoporosis	0.00012	0.000856	CcSEcCtD
Fluorouracil—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000119	0.000851	CcSEcCtD
Fluorouracil—Hypersensitivity—Pamidronate—osteoporosis	0.000119	0.000849	CcSEcCtD
Fluorouracil—Chest pain—Estradiol—osteoporosis	0.000119	0.000847	CcSEcCtD
Fluorouracil—Myalgia—Estradiol—osteoporosis	0.000119	0.000847	CcSEcCtD
Fluorouracil—Urticaria—Zoledronate—osteoporosis	0.000117	0.000837	CcSEcCtD
Fluorouracil—Discomfort—Estradiol—osteoporosis	0.000117	0.000836	CcSEcCtD
Fluorouracil—Body temperature increased—Zoledronate—osteoporosis	0.000117	0.000832	CcSEcCtD
Fluorouracil—Diarrhoea—Risedronate—osteoporosis	0.000116	0.00083	CcSEcCtD
Fluorouracil—Dizziness—Ethinyl Estradiol—osteoporosis	0.000115	0.000823	CcSEcCtD
Fluorouracil—Confusional state—Estradiol—osteoporosis	0.000115	0.000818	CcSEcCtD
Fluorouracil—Pruritus—Pamidronate—osteoporosis	0.000114	0.000816	CcSEcCtD
Fluorouracil—Anaphylactic shock—Estradiol—osteoporosis	0.000114	0.000812	CcSEcCtD
Fluorouracil—Oedema—Estradiol—osteoporosis	0.000114	0.000812	CcSEcCtD
Fluorouracil—Infection—Estradiol—osteoporosis	0.000113	0.000806	CcSEcCtD
Fluorouracil—Urticaria—Conjugated Estrogens—osteoporosis	0.000113	0.000806	CcSEcCtD
Fluorouracil—Dizziness—Risedronate—osteoporosis	0.000113	0.000802	CcSEcCtD
Fluorouracil—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000112	0.000802	CcSEcCtD
Fluorouracil—Nervous system disorder—Estradiol—osteoporosis	0.000112	0.000796	CcSEcCtD
Fluorouracil—Tachycardia—Estradiol—osteoporosis	0.000111	0.000792	CcSEcCtD
Fluorouracil—Vomiting—Ethinyl Estradiol—osteoporosis	0.000111	0.000791	CcSEcCtD
Fluorouracil—Diarrhoea—Pamidronate—osteoporosis	0.000111	0.000789	CcSEcCtD
Fluorouracil—Rash—Ethinyl Estradiol—osteoporosis	0.00011	0.000784	CcSEcCtD
Fluorouracil—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00011	0.000784	CcSEcCtD
Fluorouracil—Headache—Ethinyl Estradiol—osteoporosis	0.000109	0.000779	CcSEcCtD
Fluorouracil—Hypersensitivity—Zoledronate—osteoporosis	0.000109	0.000776	CcSEcCtD
Fluorouracil—Vomiting—Risedronate—osteoporosis	0.000108	0.000771	CcSEcCtD
Fluorouracil—Rash—Risedronate—osteoporosis	0.000107	0.000765	CcSEcCtD
Fluorouracil—Dermatitis—Risedronate—osteoporosis	0.000107	0.000764	CcSEcCtD
Fluorouracil—Dizziness—Pamidronate—osteoporosis	0.000107	0.000762	CcSEcCtD
Fluorouracil—Headache—Risedronate—osteoporosis	0.000107	0.00076	CcSEcCtD
Fluorouracil—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000105	0.000747	CcSEcCtD
Fluorouracil—Pruritus—Zoledronate—osteoporosis	0.000105	0.000745	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000104	0.000739	CcSEcCtD
Fluorouracil—Nausea—Ethinyl Estradiol—osteoporosis	0.000104	0.000739	CcSEcCtD
Fluorouracil—Insomnia—Estradiol—osteoporosis	0.000103	0.000734	CcSEcCtD
Fluorouracil—Vomiting—Pamidronate—osteoporosis	0.000103	0.000733	CcSEcCtD
Fluorouracil—Paraesthesia—Estradiol—osteoporosis	0.000102	0.000729	CcSEcCtD
Fluorouracil—Rash—Pamidronate—osteoporosis	0.000102	0.000727	CcSEcCtD
Fluorouracil—Dermatitis—Pamidronate—osteoporosis	0.000102	0.000726	CcSEcCtD
Fluorouracil—Dyspnoea—Estradiol—osteoporosis	0.000102	0.000724	CcSEcCtD
Fluorouracil—Headache—Pamidronate—osteoporosis	0.000101	0.000722	CcSEcCtD
Fluorouracil—Somnolence—Estradiol—osteoporosis	0.000101	0.000721	CcSEcCtD
Fluorouracil—Diarrhoea—Zoledronate—osteoporosis	0.000101	0.000721	CcSEcCtD
Fluorouracil—Nausea—Risedronate—osteoporosis	0.000101	0.00072	CcSEcCtD
Fluorouracil—Pruritus—Conjugated Estrogens—osteoporosis	0.000101	0.000717	CcSEcCtD
Fluorouracil—Dyspepsia—Estradiol—osteoporosis	0.0001	0.000714	CcSEcCtD
Fluorouracil—Decreased appetite—Estradiol—osteoporosis	9.9e-05	0.000705	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Estradiol—osteoporosis	9.83e-05	0.000701	CcSEcCtD
Fluorouracil—Dizziness—Zoledronate—osteoporosis	9.77e-05	0.000696	CcSEcCtD
Fluorouracil—Pain—Estradiol—osteoporosis	9.74e-05	0.000694	CcSEcCtD
Fluorouracil—Diarrhoea—Conjugated Estrogens—osteoporosis	9.73e-05	0.000694	CcSEcCtD
Fluorouracil—Nausea—Pamidronate—osteoporosis	9.61e-05	0.000685	CcSEcCtD
Fluorouracil—Dizziness—Conjugated Estrogens—osteoporosis	9.41e-05	0.000671	CcSEcCtD
Fluorouracil—Vomiting—Zoledronate—osteoporosis	9.39e-05	0.00067	CcSEcCtD
Fluorouracil—Feeling abnormal—Estradiol—osteoporosis	9.38e-05	0.000669	CcSEcCtD
Fluorouracil—Rash—Zoledronate—osteoporosis	9.32e-05	0.000664	CcSEcCtD
Fluorouracil—Dermatitis—Zoledronate—osteoporosis	9.31e-05	0.000663	CcSEcCtD
Fluorouracil—Headache—Zoledronate—osteoporosis	9.26e-05	0.00066	CcSEcCtD
Fluorouracil—Vomiting—Conjugated Estrogens—osteoporosis	9.05e-05	0.000645	CcSEcCtD
Fluorouracil—Urticaria—Estradiol—osteoporosis	9.05e-05	0.000645	CcSEcCtD
Fluorouracil—Body temperature increased—Estradiol—osteoporosis	9e-05	0.000642	CcSEcCtD
Fluorouracil—Rash—Conjugated Estrogens—osteoporosis	8.97e-05	0.000639	CcSEcCtD
Fluorouracil—Dermatitis—Conjugated Estrogens—osteoporosis	8.96e-05	0.000639	CcSEcCtD
Fluorouracil—Headache—Conjugated Estrogens—osteoporosis	8.91e-05	0.000635	CcSEcCtD
Fluorouracil—Nausea—Zoledronate—osteoporosis	8.78e-05	0.000626	CcSEcCtD
Fluorouracil—Nausea—Conjugated Estrogens—osteoporosis	8.45e-05	0.000602	CcSEcCtD
Fluorouracil—Hypersensitivity—Estradiol—osteoporosis	8.39e-05	0.000598	CcSEcCtD
Fluorouracil—Pruritus—Estradiol—osteoporosis	8.06e-05	0.000574	CcSEcCtD
Fluorouracil—Diarrhoea—Estradiol—osteoporosis	7.79e-05	0.000555	CcSEcCtD
Fluorouracil—Dizziness—Estradiol—osteoporosis	7.53e-05	0.000537	CcSEcCtD
Fluorouracil—Vomiting—Estradiol—osteoporosis	7.24e-05	0.000516	CcSEcCtD
Fluorouracil—Rash—Estradiol—osteoporosis	7.18e-05	0.000512	CcSEcCtD
Fluorouracil—Dermatitis—Estradiol—osteoporosis	7.17e-05	0.000511	CcSEcCtD
Fluorouracil—Headache—Estradiol—osteoporosis	7.13e-05	0.000508	CcSEcCtD
Fluorouracil—Nausea—Estradiol—osteoporosis	6.76e-05	0.000482	CcSEcCtD
Fluorouracil—TYMS—Metabolism—GAPDH—osteoporosis	2.66e-05	0.000255	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.65e-05	0.000254	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP27A1—osteoporosis	2.64e-05	0.000253	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	2.63e-05	0.000252	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—RAP1A—osteoporosis	2.59e-05	0.000248	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.58e-05	0.000247	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CALCA—osteoporosis	2.58e-05	0.000247	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ACP5—osteoporosis	2.56e-05	0.000246	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.53e-05	0.000243	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.53e-05	0.000243	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.52e-05	0.000241	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PNP—osteoporosis	2.49e-05	0.000239	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ATIC—osteoporosis	2.49e-05	0.000239	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—MTHFR—osteoporosis	2.46e-05	0.000236	CbGpPWpGaD
Fluorouracil—ABCC3—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.42e-05	0.000232	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.41e-05	0.000231	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.4e-05	0.00023	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TNF—osteoporosis	2.4e-05	0.00023	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.4e-05	0.00023	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—TPI1—osteoporosis	2.38e-05	0.000229	CbGpPWpGaD
Fluorouracil—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	2.38e-05	0.000228	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	2.38e-05	0.000228	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ENO1—osteoporosis	2.35e-05	0.000225	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KL—osteoporosis	2.34e-05	0.000224	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—OXCT1—osteoporosis	2.33e-05	0.000224	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CA2—osteoporosis	2.33e-05	0.000224	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PSMA5—osteoporosis	2.32e-05	0.000222	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PSMA2—osteoporosis	2.32e-05	0.000222	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MGLL—osteoporosis	2.27e-05	0.000218	CbGpPWpGaD
Fluorouracil—ABCC4—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.27e-05	0.000218	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.26e-05	0.000217	CbGpPWpGaD
Fluorouracil—TYMS—Circadian rythm related genes—IL6—osteoporosis	2.26e-05	0.000216	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—RAP1A—osteoporosis	2.25e-05	0.000216	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—P4HB—osteoporosis	2.24e-05	0.000215	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.24e-05	0.000215	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.24e-05	0.000215	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.2e-05	0.000211	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—TGFB1—osteoporosis	2.2e-05	0.000211	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GAPDH—osteoporosis	2.2e-05	0.000211	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	2.16e-05	0.000207	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CYP19A1—osteoporosis	2.16e-05	0.000207	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.15e-05	0.000206	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—RAP1A—osteoporosis	2.14e-05	0.000205	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.14e-05	0.000205	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CA2—osteoporosis	2.12e-05	0.000203	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—OXCT1—osteoporosis	2.12e-05	0.000203	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ADCY5—osteoporosis	2.1e-05	0.000202	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	2.1e-05	0.000201	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ENO1—osteoporosis	2.09e-05	0.000201	CbGpPWpGaD
Fluorouracil—CYP2C8—Biological oxidations—POMC—osteoporosis	2.08e-05	0.0002	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MGLL—osteoporosis	2.07e-05	0.000198	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PSMA2—osteoporosis	2.06e-05	0.000198	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PSMA5—osteoporosis	2.06e-05	0.000198	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.06e-05	0.000198	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—FGA—osteoporosis	2.04e-05	0.000195	CbGpPWpGaD
Fluorouracil—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	2e-05	0.000192	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—POMC—osteoporosis	1.97e-05	0.000188	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PKM—osteoporosis	1.96e-05	0.000188	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—FDPS—osteoporosis	1.96e-05	0.000188	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PKM—osteoporosis	1.95e-05	0.000187	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—FDPS—osteoporosis	1.95e-05	0.000187	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—IL6—osteoporosis	1.94e-05	0.000186	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—IDH2—osteoporosis	1.93e-05	0.000185	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—TNF—osteoporosis	1.91e-05	0.000183	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CYP19A1—osteoporosis	1.88e-05	0.00018	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.87e-05	0.000179	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PGLS—osteoporosis	1.86e-05	0.000178	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPD2—osteoporosis	1.86e-05	0.000178	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—IGF1—osteoporosis	1.86e-05	0.000178	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—FGB—osteoporosis	1.86e-05	0.000178	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPD2—osteoporosis	1.85e-05	0.000177	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PGLS—osteoporosis	1.85e-05	0.000177	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IRS2—osteoporosis	1.84e-05	0.000177	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ADCY5—osteoporosis	1.83e-05	0.000176	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP27A1—osteoporosis	1.82e-05	0.000174	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ACP5—osteoporosis	1.77e-05	0.000169	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ADCY5—osteoporosis	1.76e-05	0.000169	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.76e-05	0.000169	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—GPX1—osteoporosis	1.76e-05	0.000168	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—IDH2—osteoporosis	1.76e-05	0.000168	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.75e-05	0.000168	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ENO1—osteoporosis	1.73e-05	0.000166	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PSMA5—osteoporosis	1.71e-05	0.000164	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PSMA2—osteoporosis	1.71e-05	0.000164	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ATIC—osteoporosis	1.7e-05	0.000163	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PNP—osteoporosis	1.7e-05	0.000163	CbGpPWpGaD
Fluorouracil—CYP2C9—Biological oxidations—POMC—osteoporosis	1.69e-05	0.000162	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ATIC—osteoporosis	1.69e-05	0.000162	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PNP—osteoporosis	1.69e-05	0.000162	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTHFR—osteoporosis	1.69e-05	0.000162	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP19A1—osteoporosis	1.67e-05	0.00016	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.67e-05	0.00016	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP27A1—osteoporosis	1.65e-05	0.000158	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TPI1—osteoporosis	1.64e-05	0.000158	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.63e-05	0.000156	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IRS1—osteoporosis	1.61e-05	0.000154	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ACP5—osteoporosis	1.61e-05	0.000154	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IRS2—osteoporosis	1.6e-05	0.000154	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—FDPS—osteoporosis	1.6e-05	0.000153	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PKM—osteoporosis	1.6e-05	0.000153	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—P4HB—osteoporosis	1.55e-05	0.000148	CbGpPWpGaD
Fluorouracil—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.54e-05	0.000147	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ADCY5—osteoporosis	1.53e-05	0.000147	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—GPX1—osteoporosis	1.53e-05	0.000147	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GAPDH—osteoporosis	1.52e-05	0.000145	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PGLS—osteoporosis	1.52e-05	0.000145	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPD2—osteoporosis	1.52e-05	0.000145	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	1.51e-05	0.000145	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6R—osteoporosis	1.51e-05	0.000145	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.5e-05	0.000144	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TPI1—osteoporosis	1.49e-05	0.000143	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—RAP1A—osteoporosis	1.48e-05	0.000142	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—POMC—osteoporosis	1.45e-05	0.000139	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CA2—osteoporosis	1.45e-05	0.000139	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—OXCT1—osteoporosis	1.45e-05	0.000139	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CA2—osteoporosis	1.44e-05	0.000138	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—OXCT1—osteoporosis	1.44e-05	0.000138	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—MTHFR—osteoporosis	1.41e-05	0.000135	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MGLL—osteoporosis	1.41e-05	0.000135	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—P4HB—osteoporosis	1.4e-05	0.000135	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MGLL—osteoporosis	1.4e-05	0.000134	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IRS1—osteoporosis	1.4e-05	0.000134	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ATIC—osteoporosis	1.39e-05	0.000133	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PNP—osteoporosis	1.39e-05	0.000133	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP19A1—osteoporosis	1.38e-05	0.000133	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GAPDH—osteoporosis	1.38e-05	0.000132	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ADCY5—osteoporosis	1.37e-05	0.000131	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PKM—osteoporosis	1.37e-05	0.000131	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—FDPS—osteoporosis	1.37e-05	0.000131	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—GPX1—osteoporosis	1.36e-05	0.000131	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—MYC—osteoporosis	1.35e-05	0.00013	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—RAP1A—osteoporosis	1.34e-05	0.000129	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.33e-05	0.000128	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.32e-05	0.000127	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6R—osteoporosis	1.31e-05	0.000126	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—POMC—osteoporosis	1.3e-05	0.000124	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPD2—osteoporosis	1.29e-05	0.000124	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PGLS—osteoporosis	1.29e-05	0.000124	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—MTHFR—osteoporosis	1.26e-05	0.00012	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—IDH2—osteoporosis	1.2e-05	0.000115	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ENO1—osteoporosis	1.19e-05	0.000114	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—IDH2—osteoporosis	1.19e-05	0.000114	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PNP—osteoporosis	1.18e-05	0.000114	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ATIC—osteoporosis	1.18e-05	0.000114	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CA2—osteoporosis	1.18e-05	0.000113	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—OXCT1—osteoporosis	1.18e-05	0.000113	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PSMA2—osteoporosis	1.18e-05	0.000113	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PSMA5—osteoporosis	1.18e-05	0.000113	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MGLL—osteoporosis	1.15e-05	0.00011	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ADCY5—osteoporosis	1.13e-05	0.000108	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—POMC—osteoporosis	1.13e-05	0.000108	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.13e-05	0.000108	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GPX1—osteoporosis	1.13e-05	0.000108	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP27A1—osteoporosis	1.12e-05	0.000107	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TGFB1—osteoporosis	1.11e-05	0.000107	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ACP5—osteoporosis	1.1e-05	0.000105	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ACP5—osteoporosis	1.09e-05	0.000105	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ENO1—osteoporosis	1.09e-05	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.08e-05	0.000104	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.08e-05	0.000104	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.08e-05	0.000103	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PSMA5—osteoporosis	1.07e-05	0.000102	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PSMA2—osteoporosis	1.07e-05	0.000102	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—MTHFR—osteoporosis	1.04e-05	9.97e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.03e-05	9.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TPI1—osteoporosis	1.02e-05	9.78e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TPI1—osteoporosis	1.01e-05	9.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CA2—osteoporosis	1.01e-05	9.65e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—OXCT1—osteoporosis	1.01e-05	9.65e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—POMC—osteoporosis	1.01e-05	9.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MGLL—osteoporosis	9.81e-06	9.41e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	9.77e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—IDH2—osteoporosis	9.76e-06	9.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—P4HB—osteoporosis	9.59e-06	9.19e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP19A1—osteoporosis	9.55e-06	9.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—P4HB—osteoporosis	9.54e-06	9.14e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GAPDH—osteoporosis	9.41e-06	9.02e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GAPDH—osteoporosis	9.36e-06	8.97e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.25e-06	8.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP27A1—osteoporosis	9.18e-06	8.8e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—RAP1A—osteoporosis	9.17e-06	8.79e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—RAP1A—osteoporosis	9.12e-06	8.74e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MYC—osteoporosis	8.95e-06	8.58e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ACP5—osteoporosis	8.93e-06	8.56e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—TGFB1—osteoporosis	8.93e-06	8.56e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.82e-06	8.45e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP19A1—osteoporosis	8.67e-06	8.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IGF1—osteoporosis	8.4e-06	8.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—IDH2—osteoporosis	8.34e-06	8e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—POMC—osteoporosis	8.32e-06	7.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TPI1—osteoporosis	8.3e-06	7.96e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8e-06	7.66e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.95e-06	7.62e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP27A1—osteoporosis	7.84e-06	7.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—P4HB—osteoporosis	7.81e-06	7.48e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ADCY5—osteoporosis	7.8e-06	7.48e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MYC—osteoporosis	7.79e-06	7.47e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GPX1—osteoporosis	7.77e-06	7.45e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—TGFB1—osteoporosis	7.77e-06	7.45e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GAPDH—osteoporosis	7.66e-06	7.34e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ACP5—osteoporosis	7.63e-06	7.31e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.53e-06	7.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—RAP1A—osteoporosis	7.46e-06	7.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ENO1—osteoporosis	7.41e-06	7.1e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ENO1—osteoporosis	7.37e-06	7.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PSMA2—osteoporosis	7.3e-06	7e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PSMA5—osteoporosis	7.3e-06	7e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PSMA2—osteoporosis	7.26e-06	6.96e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PSMA5—osteoporosis	7.26e-06	6.96e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—osteoporosis	7.17e-06	6.88e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TPI1—osteoporosis	7.09e-06	6.8e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ADCY5—osteoporosis	7.09e-06	6.79e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GPX1—osteoporosis	7.06e-06	6.77e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—IL6—osteoporosis	6.73e-06	6.45e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—P4HB—osteoporosis	6.67e-06	6.39e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GAPDH—osteoporosis	6.55e-06	6.28e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—osteoporosis	6.52e-06	6.25e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.51e-06	6.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—RAP1A—osteoporosis	6.38e-06	6.11e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ENO1—osteoporosis	6.03e-06	5.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PSMA2—osteoporosis	5.94e-06	5.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PSMA5—osteoporosis	5.94e-06	5.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP19A1—osteoporosis	5.93e-06	5.68e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP19A1—osteoporosis	5.89e-06	5.65e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—IL6—osteoporosis	5.86e-06	5.61e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—POMC—osteoporosis	5.74e-06	5.5e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.56e-06	5.33e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—POMC—osteoporosis	5.21e-06	5e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ENO1—osteoporosis	5.15e-06	4.94e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PSMA5—osteoporosis	5.08e-06	4.87e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PSMA2—osteoporosis	5.08e-06	4.87e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TGFB1—osteoporosis	5.04e-06	4.83e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ADCY5—osteoporosis	4.84e-06	4.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPX1—osteoporosis	4.82e-06	4.62e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP19A1—osteoporosis	4.82e-06	4.62e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ADCY5—osteoporosis	4.81e-06	4.61e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPX1—osteoporosis	4.8e-06	4.6e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—osteoporosis	4.45e-06	4.27e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—osteoporosis	4.43e-06	4.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP19A1—osteoporosis	4.12e-06	3.95e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ADCY5—osteoporosis	3.94e-06	3.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPX1—osteoporosis	3.93e-06	3.76e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—osteoporosis	3.62e-06	3.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—POMC—osteoporosis	3.56e-06	3.41e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—POMC—osteoporosis	3.54e-06	3.39e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ADCY5—osteoporosis	3.37e-06	3.23e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPX1—osteoporosis	3.36e-06	3.22e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—osteoporosis	3.1e-06	2.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—POMC—osteoporosis	2.9e-06	2.78e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—POMC—osteoporosis	2.48e-06	2.37e-05	CbGpPWpGaD
